|
| Join us in an upcoming webinar discussing mechanisms that inhibit T cells from inducing anti-tumor immunity. Dr. Vijay Kuchroo will describe using single-cell technologies to identify novel checkpoint molecules on effector T cells. Learn why checkpoint blockade doesn’t induce a complete anti-tumor immune response in all patients and how soluble factors contribute to anti-tumor immunity. |
|||||||
|
